dr. herbst on next-generation agents in nsclc
Published 8 years ago • 117 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
1:03
dr. herbst on combination therapies for lung cancer
-
0:46
dr. herbst on nivolumab for nsclc
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:14
dr. herbst on long term survival with pembrolizumab in nsclc
-
1:13
dr. herbst on targeting pd-1 and pd-l1 in lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
2:50
next-generation alk-targeted agents in nsclc
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
1:00
dr. herbst discusses immunotherapy in lung cancer